Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants.
Innovative and easy-to-implement strategies are needed to improve the pathogenicity assessment of rare germline missense variants. Somatic cancer driver mutations identified through large-scale tumor sequencing studies often impact genes that are also associated with rare Mendelian disorders. The us...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2025-01-01
|
| Serija: | PLoS Genetics |
| Online pristup: | https://doi.org/10.1371/journal.pgen.1011540 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
